• 四川大學(xué)華西醫(yī)院普外科（成都610041）;

引用本文： 熊先澤,程南生. 肝切除術(shù)后肝功能不全的防治. 中國普外基礎(chǔ)與臨床雜志, 2004, 11(5): 466-469. doi: 復(fù)制

1. 李波,嚴(yán)律南. 肝硬變患者部分肝切除術(shù)后肝功能衰竭的預(yù)防 [J]. 中國現(xiàn)代普通外科進(jìn)展, 2001； 4(3)∶142.
2. 章園,向進(jìn)見,沈世強(qiáng),等.肝切除時的局部肝保護(hù) [J]. 肝膽胰外科雜志, 2003， 15(2)∶139.
3. de Baere T, Roche A, Elias D, et al. Preoperative portal vein embolization for extension of hepatectomy indications [J]. Hepatology, 1996; 24(6)∶1386.
4. 沈世強(qiáng)，張訓(xùn)臣，王衛(wèi)星，等. 肝切除時門靜脈血部分動脈化的研究 [J]. 中華實(shí)驗(yàn)外科雜志， 2000； 17（3）∶235.
5. Hannoun L, Delriviere L, Gibbs P, et al. Major extended hepatic resections in diseased livers using hypothermic protection: preliminary results from the first 12 patients treated with this new technique [J]. J Am Coll Surg, 1996; 183(6)∶597.
6. Yamanaka N, Okamoto E, Fujiwara S, et al. Hepatic resection under liver surface or perfusion cooling together with hepatoprotective agents of PGE1 and urinastatin [J]. Nippon Geka Gakkai Zasshi, 1993; 94(3)∶259.
7. Hossain MA, Hamamoto I, Wakabayashi H, et al. Experimental study of the effect of intraportal prostaglandin E1 on hepatic blood flow during reperfusion after ischaemia and hepatectomy [J]. Br J Surg, 1999; 86(6)∶776.
8. Katsuramaki T, Mukaiya M, Yamashiro K, et al. Beneficial effects of administering intraportal prostaglandin E1 postoperatively to hepatectomy patients with massive intraoperative blood loss [J]. Surg Today, 1996; 26(11)∶895.
9. Sato T, Asanuma Y, Kuyokawa T, et al. Prostaglandin E1 continuous hepatic arterial infusion in the treatment of postoperative acute liver failure: basic study on hepatic hemodynamics and clinical application [J]. Dig Surg, 2000; 17（3）∶234.
10. Miyazaki M, Makowka L, Falk RE, et al. Protection of thermochemotherapeuticinduced lethal acute hepatic necrosis in the rat by 16,16dimethyl prostaglandin E2 [J]. J Surg Res, 1983; 34(5)∶415.
11. Kogure K, Omata W, Kanzaki M, et al. A single intraportal administration of follistatin accelerates liver regeneration in partially hepatectomized rats [J]. Gastroenterology, 1995; 108(4)∶1136.
12. Rokicki M, Rokicki W, Czyzewski K. Effect of long term insulin infusion into rat portal vein on regenerating liver [J]. Mater Med Pol, 1990; 22(2)∶93.
13. 王在國，丁福全，劉光中，等. 門靜脈激素療法對肝切除術(shù)后的肝衰的預(yù)防價值 [J]. 中華肝膽外科雜志， 1998； 4（6）∶402.
14. Nakai T, Tanimura H, Yamoto H, et al. Improved liver function following infusion of fructose1, 6bisphosphate in posthepatectomy patients [J]. Nippon Geka Hokan, 1996; 65(1)∶3.
15. Ohtake M, Sandoh N, Sakaguchi T, et al. Enhancement of portal blood flow by ursodesoxycholic acid in partially hepatectomized rats [J]. Surg Today, 1996; 26(2)∶142.
16. 王正康,周雷. 術(shù)后急性肝功能不全的救治 [J]. 醫(yī)學(xué)新知雜志, 2003； 13(2)∶57.
  1. 1. 李波,嚴(yán)律南. 肝硬變患者部分肝切除術(shù)后肝功能衰竭的預(yù)防 [J]. 中國現(xiàn)代普通外科進(jìn)展, 2001； 4(3)∶142.
  2. 2. 章園,向進(jìn)見,沈世強(qiáng),等.肝切除時的局部肝保護(hù) [J]. 肝膽胰外科雜志, 2003， 15(2)∶139.
  3. 3. de Baere T, Roche A, Elias D, et al. Preoperative portal vein embolization for extension of hepatectomy indications [J]. Hepatology, 1996; 24(6)∶1386.
  4. 4. 沈世強(qiáng)，張訓(xùn)臣，王衛(wèi)星，等. 肝切除時門靜脈血部分動脈化的研究 [J]. 中華實(shí)驗(yàn)外科雜志， 2000； 17（3）∶235.
  5. 5. Hannoun L, Delriviere L, Gibbs P, et al. Major extended hepatic resections in diseased livers using hypothermic protection: preliminary results from the first 12 patients treated with this new technique [J]. J Am Coll Surg, 1996; 183(6)∶597.
  6. 6. Yamanaka N, Okamoto E, Fujiwara S, et al. Hepatic resection under liver surface or perfusion cooling together with hepatoprotective agents of PGE1 and urinastatin [J]. Nippon Geka Gakkai Zasshi, 1993; 94(3)∶259.
  7. 7. Hossain MA, Hamamoto I, Wakabayashi H, et al. Experimental study of the effect of intraportal prostaglandin E1 on hepatic blood flow during reperfusion after ischaemia and hepatectomy [J]. Br J Surg, 1999; 86(6)∶776.
  8. 8. Katsuramaki T, Mukaiya M, Yamashiro K, et al. Beneficial effects of administering intraportal prostaglandin E1 postoperatively to hepatectomy patients with massive intraoperative blood loss [J]. Surg Today, 1996; 26(11)∶895.
  9. 9. Sato T, Asanuma Y, Kuyokawa T, et al. Prostaglandin E1 continuous hepatic arterial infusion in the treatment of postoperative acute liver failure: basic study on hepatic hemodynamics and clinical application [J]. Dig Surg, 2000; 17（3）∶234.
  10. 10. Miyazaki M, Makowka L, Falk RE, et al. Protection of thermochemotherapeuticinduced lethal acute hepatic necrosis in the rat by 16,16dimethyl prostaglandin E2 [J]. J Surg Res, 1983; 34(5)∶415.
  11. 11. Kogure K, Omata W, Kanzaki M, et al. A single intraportal administration of follistatin accelerates liver regeneration in partially hepatectomized rats [J]. Gastroenterology, 1995; 108(4)∶1136.
  12. 12. Rokicki M, Rokicki W, Czyzewski K. Effect of long term insulin infusion into rat portal vein on regenerating liver [J]. Mater Med Pol, 1990; 22(2)∶93.
  13. 13. 王在國，丁福全，劉光中，等. 門靜脈激素療法對肝切除術(shù)后的肝衰的預(yù)防價值 [J]. 中華肝膽外科雜志， 1998； 4（6）∶402.
  14. 14. Nakai T, Tanimura H, Yamoto H, et al. Improved liver function following infusion of fructose1, 6bisphosphate in posthepatectomy patients [J]. Nippon Geka Hokan, 1996; 65(1)∶3.
  15. 15. Ohtake M, Sandoh N, Sakaguchi T, et al. Enhancement of portal blood flow by ursodesoxycholic acid in partially hepatectomized rats [J]. Surg Today, 1996; 26(2)∶142.
  16. 16. 王正康,周雷. 術(shù)后急性肝功能不全的救治 [J]. 醫(yī)學(xué)新知雜志, 2003； 13(2)∶57.